Dynamic changes of Kisspeptin during controlled ovarian hyperstimulation (COH) in polycystic ovary syndrome patients and its correlation with COH outcomes.

Saved in:
Bibliographic Details
Title: Dynamic changes of Kisspeptin during controlled ovarian hyperstimulation (COH) in polycystic ovary syndrome patients and its correlation with COH outcomes.
Authors: Han L; Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China.; Tianjin Key Laboratory of Female Reproductive Health and Eugenic, Tianjin Medical University General Hospital, Tianjin, China., Wang Y; Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China.; Tianjin Key Laboratory of Female Reproductive Health and Eugenic, Tianjin Medical University General Hospital, Tianjin, China., Li Y; Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China.; Tianjin Key Laboratory of Female Reproductive Health and Eugenic, Tianjin Medical University General Hospital, Tianjin, China., Li X; Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China.; Tianjin Key Laboratory of Female Reproductive Health and Eugenic, Tianjin Medical University General Hospital, Tianjin, China., Zhang J; Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China.; Tianjin Key Laboratory of Female Reproductive Health and Eugenic, Tianjin Medical University General Hospital, Tianjin, China., Zhang Y; Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China.; Tianjin Key Laboratory of Female Reproductive Health and Eugenic, Tianjin Medical University General Hospital, Tianjin, China., Zhao M; Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China.; Tianjin Key Laboratory of Female Reproductive Health and Eugenic, Tianjin Medical University General Hospital, Tianjin, China., Chen H; Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China.; Tianjin Key Laboratory of Female Reproductive Health and Eugenic, Tianjin Medical University General Hospital, Tianjin, China., Zhang H; Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China.; Tianjin Key Laboratory of Female Reproductive Health and Eugenic, Tianjin Medical University General Hospital, Tianjin, China., Wang Y; Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China.; Tianjin Key Laboratory of Female Reproductive Health and Eugenic, Tianjin Medical University General Hospital, Tianjin, China., Xue F; Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China.; Tianjin Key Laboratory of Female Reproductive Health and Eugenic, Tianjin Medical University General Hospital, Tianjin, China., Tian W; Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, China.; Tianjin Key Laboratory of Female Reproductive Health and Eugenic, Tianjin Medical University General Hospital, Tianjin, China.
Source: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2026 May 20; Vol. 17, pp. 1835699. Date of Electronic Publication: 2026 May 20 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-2392
DOI:10.3389/fendo.2026.1835699